Results from xenograft models indicated that AMDHD1 overexpression significantly reduced tumor growth rates and resulted in lower tumor weights in the AMDHD1-OV group compared with controls at the study’s conclusion (Fig. 2K–M). The gene discussed is AMDHD1; the disease is neoplasm.